Proper molecular testing is critical for Africa, where most patients are treatment naïve. Therefore they will have a positive response to inexpensive, first-line therapy. If therapy is not managed with adequate testing, patients' HIV will develop resistance quickly – a complication for an already dire situation.

Molecular testing consists of:

• The most effective way for viral load monitoring
• Identification of HIV drug resistant variants

bDNA (branched DNA) analysis:

• Robust way to measure viral load
• No need for amplification of the virus
• No need for separate clean area
• The same high-quality results as those obtained in urban clinical laboratories

Related Links